BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32434219)

  • 1. Distinct fibroblast functional states drive clinical outcomes in ovarian cancer and are regulated by TCF21.
    Hussain A; Voisin V; Poon S; Karamboulas C; Bui NHB; Meens J; Dmytryshyn J; Ho VW; Tang KH; Paterson J; Clarke BA; Bernardini MQ; Bader GD; Neel BG; Ailles LE
    J Exp Med; 2020 Aug; 217(8):. PubMed ID: 32434219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAP
    Sun L; Ke M; Wang X; Yin M; Wei J; Xu L; Tian X; Wang F; Zhang H; Fu S; Zhang C
    Mol Carcinog; 2022 Oct; 61(10):910-923. PubMed ID: 35801406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Signal transducer and activator of transcription 3 and cancer associated fibroblasts jointly generate chemo-resistance and affect prognosis in epithelial ovarian cancer].
    Zhang YN; Li B; Li YQ; Liu SH; Hou HY; Wang KY; Ao M; Song Y
    Zhonghua Fu Chan Ke Za Zhi; 2023 May; 58(5):368-377. PubMed ID: 37217344
    [No Abstract]   [Full Text] [Related]  

  • 4. The β-arrestin1/endothelin axis bolsters ovarian fibroblast-dependent invadosome activity and cancer cell metastatic potential.
    Del Rio D; Masi I; Caprara V; Ottavi F; Albertini Petroni G; Salvati E; Trisciuoglio D; Giannitelli SM; Bagnato A; Mauri E; Spadaro F; Rosanò L
    Cell Death Dis; 2024 May; 15(5):358. PubMed ID: 38777849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts.
    Radhakrishnan R; Ha JH; Jayaraman M; Liu J; Moxley KM; Isidoro C; Sood AK; Song YS; Dhanasekaran DN
    Cancer Lett; 2019 Feb; 442():464-474. PubMed ID: 30503552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors.
    Cremasco V; Astarita JL; Grauel AL; Keerthivasan S; MacIsaac K; Woodruff MC; Wu M; Spel L; Santoro S; Amoozgar Z; Laszewski T; Migoni SC; Knoblich K; Fletcher AL; LaFleur M; Wucherpfennig KW; Pure E; Dranoff G; Carroll MC; Turley SJ
    Cancer Immunol Res; 2018 Dec; 6(12):1472-1485. PubMed ID: 30266714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer.
    Zhao L; Ji G; Le X; Wang C; Xu L; Feng M; Zhang Y; Yang H; Xuan Y; Yang Y; Lei L; Yang Q; Lau WB; Lau B; Chen Y; Deng X; Yao S; Yi T; Zhao X; Wei Y; Zhou S
    Cancer Res; 2017 Mar; 77(6):1369-1382. PubMed ID: 28087599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-Met/PI3K/Akt and GRP78 signalling in ovarian cancer cells.
    Deying W; Feng G; Shumei L; Hui Z; Ming L; Hongqing W
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28258248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COL11A1 activates cancer-associated fibroblasts by modulating TGF-β3 through the NF-κB/IGFBP2 axis in ovarian cancer cells.
    Wu YH; Huang YF; Chang TH; Chen CC; Wu PY; Huang SC; Chou CY
    Oncogene; 2021 Jul; 40(26):4503-4519. PubMed ID: 34117361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion.
    Hao J; Zeltz C; Pintilie M; Li Q; Sakashita S; Wang T; Cabanero M; Martins-Filho SN; Wang DY; Pasko E; Venkat K; Joseph J; Raghavan V; Zhu CQ; Wang YH; Moghal N; Tsao MS; Navab R
    Neoplasia; 2019 May; 21(5):482-493. PubMed ID: 30978569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis.
    Paauwe M; Schoonderwoerd MJA; Helderman RFCP; Harryvan TJ; Groenewoud A; van Pelt GW; Bor R; Hemmer DM; Versteeg HH; Snaar-Jagalska BE; Theuer CP; Hardwick JCH; Sier CFM; Ten Dijke P; Hawinkels LJAC
    Clin Cancer Res; 2018 Dec; 24(24):6331-6344. PubMed ID: 29945992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):340-351. PubMed ID: 32496971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLIS1 in Cancer-Associated Fibroblasts Regulates the Migration and Invasion of Ovarian Cancer Cells.
    Kim MJ; Jung D; Park JY; Lee SM; An HJ
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis.
    Yang Z; Xu S; Jin P; Yang X; Li X; Wan D; Zhang T; Long S; Wei X; Chen G; Meng L; Liu D; Fang Y; Chen P; Ma D; Gao Q
    Oncotarget; 2016 Jun; 7(25):37649-37663. PubMed ID: 27081703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.
    Zou R; Jiang Q; Jin T; Chen M; Yao L; Ding H
    Front Immunol; 2022; 13():956224. PubMed ID: 36032075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression.
    Jena BC; Das CK; Bharadwaj D; Mandal M
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188416. PubMed ID: 32822826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In search of definitions: Cancer-associated fibroblasts and their markers.
    Nurmik M; Ullmann P; Rodriguez F; Haan S; Letellier E
    Int J Cancer; 2020 Feb; 146(4):895-905. PubMed ID: 30734283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.
    Sandberg TP; Stuart MPME; Oosting J; Tollenaar RAEM; Sier CFM; Mesker WE
    BMC Cancer; 2019 Mar; 19(1):284. PubMed ID: 30922247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms.
    Pelon F; Bourachot B; Kieffer Y; Magagna I; Mermet-Meillon F; Bonnet I; Costa A; Givel AM; Attieh Y; Barbazan J; Bonneau C; Fuhrmann L; Descroix S; Vignjevic D; Silberzan P; Parrini MC; Vincent-Salomon A; Mechta-Grigoriou F
    Nat Commun; 2020 Jan; 11(1):404. PubMed ID: 31964880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
    Zhao L; Ji G; Le X; Luo Z; Wang C; Feng M; Xu L; Zhang Y; Lau WB; Lau B; Yang Y; Lei L; Yang H; Xuan Y; Chen Y; Deng X; Yi T; Yao S; Zhao X; Wei Y; Zhou S
    Oncogene; 2017 Jun; 36(24):3384-3396. PubMed ID: 28114283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.